Home / Markets / Poland

Market requirements · PL

Poland

2 dated sources Reviewed 2026-08-20 Next review 2026-11-18

GIF and GIS have issued a joint public warning on synthetic peptides offered as chemical reagents. The Polish position turns on how a product is packaged and promoted.

Buyers in this market search for: peptydy hurt, hurtownia peptydow, peptydy badawcze sprzedaz hurtowa.

Tell us the compounds you need for Poland.Ask about Poland

The regime

How compounds are classified in Poland

Governing lawPolish pharmaceutical law, administered by the Glowny Inspektorat Farmaceutyczny with the Glowny Inspektorat Sanitarny on the sanitary side.
The regulators' stated positionGIF and GIS issued a joint public warning concerning synthetic peptides offered online as chemical reagents or reference materials for scientific research. They stated that packaging and promotion of that kind indicates circumvention for human use, and that the trade constitutes illegal trade carrying criminal liability.
What triggers itThe warning focuses on presentation. Vials, pens, ampoules, suggested dosages and dosage calculators were cited as indicators that a product marketed as a reagent is intended for human use.
Prescription-only compoundsThe gonadotropins and somatropin follow the EU prescription-medicine position.
Enforcement postureA named, dated government warning specific to research-labelled peptides. Alongside Slovenia, this is the most explicit regulator statement found anywhere in the EU on this exact product framing.
Already supplying Poland? Send the compounds and volumes you buy today and we will quote against them.Send your list

Your obligations

What a buyer in Poland needs settled

  • Hold the Polish authorisation your intended activity requires before importing.
  • Pay particular attention to presentation. The Polish position turns on how a product is packaged and promoted, not only on what it is.
  • Avoid dosage guidance, dosage calculators and administration formats in any Polish-facing material.
  • Take Polish counsel before supplying into the market.

We will ask about this at enquiry. We check the authorisations your activity requires before quoting, and we confirm the position per compound rather than for the market as a whole.

Sources

Check this yourself

Every position above traces to a dated public document. The authority, the document, the date and the link are below.

Authority and documentDateLink
GIF and GIS
Joint public warning on illegal trade in synthetic peptides
undatedwww.gov.pl/web/gif/nielegalny-obrot-syntetycznymi-peptydam...
WSSE Wroclaw
Public warning, regional publication of the same notice
undatedwww.gov.pl/web/wsse-wroclaw/ostrzezenie-publiczne-nielegal...

Links go to the issuing body wherever one exists. Positions change. If you are relying on any of this, check the source rather than this page.

Market brief

Take the Poland brief as a PDF

The regime, the buyer obligations and all 2 sources, dated and linked, in one document you can forward.

Nearby

Central and Eastern Europe and nearby markets

Buyers supplying one of these usually supply the others. The requirements are not the same.

CodeMarketSources
CZCzechia2 sourcesSUKL holds that most synthetic peptides meet the functional definition of a me...
SKSlovakia3 sourcesSUKL named BPC-157, ipamorelin and melanotan directly in a July 2025 press rel...
HUHungary5 sourcesOGYEI regulates medicines under Act XCV of 2005. A case-by-case research permi...
HRCroatia1 sourcesHALMED has published a general rule on online medicine sales. No notice naming...
SISlovenia2 sourcesJAZMP published a dated warning on injectable peptides in April 2026 and names...
FRFrance3 sourcesANSM names compounds individually in its public alerts and has issued sanitary...

Scope

How to use this page

A summary of the published regulatory position in Poland as at 2026-08-20, written for procurement teams deciding how to source. Every source is dated and linked so it can be checked at origin.

It is not legal advice. Full terms of supply, including where responsibility sits, are set out in our terms of supply.

Questions

Supplying into Poland

Do you supply into Poland?

We supply businesses that hold the authorisations their activity requires. Whether a specific compound can be supplied into Poland depends on that compound and on your authorisations, and we confirm it per compound at the enquiry stage.

Who carries the compliance obligation?

The importer of record and the party placing the product on the market, which is the buyer. We supply the batch documentation that supports your file. We cannot hold your authorisations for you.

How current is this page?

It was reviewed on 2026-08-20 and is scheduled for review again on 2026-11-18. Every source is dated and linked, so you can check the original.

We already supply into Poland. What changes if we source from you?

The batch documentation. You receive a Certificate of Analysis per batch, which can be issued under your own brand. The import and market-placing responsibilities stay where they are.

Is this legal advice?

No. It is a summary of the regulatory positions those authorities have published, as at the review date above. Take advice in your own market before you rely on it.

Enquire about supply into Poland

Tell us the compounds and your authorisations. We confirm per compound before anything ships.

Anything else you already know. All optional.

We supply businesses across the EU, and we reply within one working day.